Clinical trials · New York, NY
Children clinical trials in New York
We’re tracking 178 recruiting children studies with a site in or near New York — including Phase 1, Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT06102941Recruiting
Cognitive training for OCD in kids aged 8 to 12
This study tests a cognitive training program to help young children with OCD. It's designed for kids whose OCD is their main problem and who are not currently on medication or in other therapy.
New York, New YorkAges 8–12 - NCT06908226Enrolling by invitationPhase 3
LP352 for children and adults with DEE
This trial tests a medication called LP352 for children and adults with certain types of epilepsy (Dravet syndrome, Lennox-Gastaut syndrome, or other developmental and epileptic encephalopathies). It's for people who already completed a previous study of LP352 and may benefit from continued treatment.
New York, New YorkAges 2–66 - NCT06712875RecruitingPhase 1/Phase 2
Brain cancer drug combo for kids with BRAF mutations
This trial tests a combination of targeted therapy (dabrafenib and trametinib) and immunotherapy (nivolumab) for children and young adults with certain BRAF gene changes in their glioma. It aims to see if this drug combination can shrink tumors or stop them from growing.
New York, New YorkAges 1–26 - NCT07298421RecruitingPhase 3
Testing afimkibart for children with Crohn's disease
This trial tests a medicine called afimkibart for children with moderately to severely active Crohn's disease. It aims to see how well the drug works and how safe it is when used for both starting and ongoing treatment.
New York, New YorkAges 2–17 - NCT06100289RecruitingPhase 3
Study of vedolizumab for kids with ulcerative colitis or Crohn's disease
This trial tests vedolizumab, a biologic medicine that reduces inflammation, in children and teenagers who have moderate to severe ulcerative colitis or Crohn's disease and have not responded well to other treatments.
New York, New YorkAges 2–17 - NCT07199465RecruitingPhase 1
Letermovir for children after a kidney transplant
This study tests an oral antiviral medication called letermovir to see if it safely prevents CMV (a common virus) in children who have recently had a kidney transplant. It's for children ages typically 4 weeks to about a year post-transplant, with stable kidney function and no current CMV infection.
New York, New YorkAges Up to 17 years - NCT07642999Recruiting
How Children's Screen Time Affects Eye Development
This study tracks how much time children spend looking at screens versus outdoor activities and how that relates to their eye health over 3 years. Researchers will give your child a special device to wear at home to measure their visual habits.
New York, New YorkAges 7–12 - NCT02193841RecruitingPhase 3
Treating simple bone cysts in children with new bone support
This study looks at how well a treatment works for children with a simple bone cyst in an arm or leg. The goal is to prevent problems like fractures while the cyst heals, using a stabilizing implant in the bone.
New York, New YorkAges 2–21 - NCT07188805RecruitingPhase 3
Finerenone for children with heart failure
This study tests a new medicine called finerenone (a pill) to see if it helps children with heart failure who have a weak pumping heart. It compares finerenone to a placebo (a pill with no medicine) while both groups continue their usual heart treatments.
New York, New YorkAges 6 months–17 years - NCT07297979RecruitingPhase 1
Xaluritamig for relapsed or refractory Ewing sarcoma
This trial is testing a new drug called xaluritamig for children, teens, and adults with Ewing sarcoma that has come back or is not responding to treatment. The goal is to see if this drug can shrink the cancer or stop it from growing.
New York, New YorkAges 2 years+ - NCT04928677RecruitingPhase 1
Codrituzumab for children and young adults with GPC3-positive solid tumors
This Phase 1 study tests codrituzumab, an antibody medicine, in children and young adults whose solid tumor has come back or did not respond to standard treatment. It’s designed to see how the treatment works and how safe it is, especially for tumors that test positive for GPC3.
New York, New YorkAges 1–21 - NCT05918640RecruitingPhase 1/Phase 2
Lurbinectedin for cancers with specific EWS-related gene fusions
This early-phase study tests lurbinectedin, a chemotherapy medicine, in children and young adults whose solid tumors have a specific “FET fusion” gene change. It may help shrink tumors that have come back or did not respond to prior treatment, depending on the exact fusion type.
New York, New YorkAges 10 years+ - NCT06212947Recruiting
An observational study for children with hypochondroplasia
This study observes children with hypochondroplasia to learn more about the condition. It does not involve any treatment—just monitoring and data collection to help future research.
New York, New YorkAges Up to 15 years - NCT05004116RecruitingPhase 1/Phase 2
Repotrectinib plus chemotherapy for relapsed solid tumors in youth
This early-phase study tests repotrectinib (a targeted anti-cancer pill) combined with chemotherapy in children and young adults whose solid tumors have come back or did not respond to standard treatment. The goal is to see how safe the treatment is and whether it can shrink tumors.
New York, New YorkAges 1–25 - NCT07243652Recruiting
Helping kids recover after bronchiolitis
This study tests a program called I-DECIDE to help children recover after being hospitalized with bronchiolitis. It may help parents manage symptoms and decide when to seek care.
New York, New YorkAges birth–2 years - NCT06524882RecruitingPhase 3
Special glasses for lazy eye in children 8 to 12 years old
This trial tests if special movies or games viewed through a headset can improve vision in children with lazy eye (amblyopia). It compares these treatments to wearing glasses alone.
New York, New YorkAges 8–12 - NCT06380517RecruitingPhase 3
Headset therapy vs patching for lazy eye in children
This study tests a new way to treat lazy eye (amblyopia) in 4 to 7 year olds using special shows watched through a headset (dichoptic therapy). It compares this to the standard treatment of wearing a patch over the stronger eye. The goal is to see if the headset therapy works as well or better than patching.
New York, New YorkAges 4–7 - NCT05547165Recruiting
Closing a leaky heart connection early in very small babies
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
New York, New YorkAges 1 week–1 month - NCT04649242RecruitingPhase 3
Migraine pain relief study for kids and teens
This trial studies a medicine for stopping a migraine attack in children and teens. It may help families understand which treatment works best during acute (during-attack) migraine pain.
New York, New YorkAges 6–17 - NCT06924307Recruiting
Parent-Child thinking skills program for ages 2-5
This trial tests a program for parents and their young children (ages 2-5) to help improve the child's thinking and self-control skills. It's designed for children without major physical or developmental challenges.
New York, New YorkAges 2–5 - NCT07223021RecruitingPhase 3
Fludarabine dosing study for B-cell ALL
This study tests a different dose of the chemotherapy drug fludarabine before CAR T-cell therapy (tisagenlecleucel) for children and young adults with B-cell acute lymphoblastic leukemia. The goal is to see if the new dose works better at helping the body accept the CAR T cells while keeping side effects manageable.
New York, New YorkAges 1 year+ - NCT07698899RecruitingPhase 1
Study of a new treatment for childhood brain and CNS cancers
This trial tests a radioactive drug (177Lu-DTPA-Omburtamab) given directly into the fluid around the brain for children and teens with certain brain cancers or cancers that have spread to the central nervous system. It aims to see if this treatment is safe and effective for tumors that have come back or not responded to other therapies.
New York, New YorkAges 3–22 - NCT07223463Recruiting
Medication support for teens and young adults with cancer
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
New York, New YorkAges 15–24 - NCT04870944RecruitingPhase 1/Phase 2
CBL0137 for children with advanced solid or brain tumors
This early-phase study tests CBL0137 in children and teens whose cancer has come back or is not responding to treatment. It is also for some specific hard-to-treat brain tumors, to see if the drug is safe and can work against the cancer.
New York, New YorkAges 1–21
Hear when a new Children trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Children trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting children studies listed above.
- Memorial Sloan Kettering Cancer Center · 8 studies
- Columbia University Irving Medical Center · 5 studies
- NYU Langone Health · 3 studies
- The Children's Hospital at Montefiore · 3 studies
- State University of New York, College of Optometry · 2 studies
- Atlantic Health System
- CHOP Pediatric Care at Penn Medicine/Princeton Health
- Columbia University Medical Center Research Pharmacy
What taking part in a children study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting children studies in New York.
Common questions
- Are there children clinical trials near New York?
- Yes. We're currently tracking 178 recruiting children studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a children study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a children trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New children studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.